Apheresis Equipment

Global Apheresis Equipment Market to Reach US$4.6 Billion by 2030

The global market for Apheresis Equipment estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Disposable Apheresis Kits, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Plasma & Component Separator segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$997.4 Million While China is Forecast to Grow at 11.3% CAGR

The Apheresis Equipment market in the U.S. is estimated at US$997.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$548.9 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Apheresis Equipment Market - Key Trends & Drivers Summarized

What Exactly Is Apheresis Equipment and How Does It Transform Lives?

Apheresis equipment refers to devices used in a medical procedure that separates the components of blood and collects one or more of these components while returning the rest to the donor or patient. This technology is vital in treating a variety of medical conditions and is used extensively in blood donation centers and hospitals. Apheresis is employed in the collection of platelets, plasma, red blood cells, and stem cells, which are critical in managing and treating conditions such as leukemia, lymphoma, various autoimmune disorders, and during chemotherapy treatments. The equipment includes a disposable kit, which ensures safety and hygiene by preventing cross-contamination, and a machine that centrifuges the blood to separate its components based on their density. This precise separation allows for targeted treatments, enhancing the effectiveness and reducing potential side effects of transfusions.

How Are Technological Advancements Elevating Apheresis Procedures?

Recent technological advancements have significantly enhanced the efficiency and safety of apheresis equipment. Modern machines are equipped with automated systems that can adjust the flow rate and the amount of anticoagulant mixed with the blood, based on real-time feedback of the blood`s characteristics. This automation minimizes the need for manual adjustments, reducing the risk of human error and increasing the comfort and safety of patients. Furthermore, the integration of advanced sensors and software analytics has improved the precision in component separation, ensuring that the extracted blood products are of high quality and the volume extracted is optimized, which is critical for patient safety and treatment efficacy. These advancements not only contribute to better health outcomes but also streamline the operation, making apheresis more accessible and faster, thereby benefiting more patients.

What Role Does Apheresis Equipment Play in Modern Medicine?

Apheresis equipment plays a crucial role in modern medicine, particularly in the treatment and management of diseases where patients require frequent transfusions or immune system modulation. For example, in therapeutic plasma exchange, the equipment is used to remove and replace plasma that contains harmful antibodies with good plasma or a plasma substitute, which can be a lifeline for patients with autoimmune diseases. Similarly, in stem cell harvesting, apheresis equipment is used to collect stem cells from a donor`s blood, which are then used in transplants to treat patients with cancers such as leukemia or lymphoma. This method is less invasive and more favorable compared to traditional bone marrow transplants. The ability of apheresis equipment to efficiently and safely collect these vital components makes it indispensable in many advanced therapeutic procedures and supports the ongoing research and clinical trials in regenerative medicine and immunotherapy.

What Drives the Growth in the Apheresis Equipment Market?

The growth in the apheresis equipment market is driven by several factors that underscore the convergence of technology, healthcare needs, and demographic shifts. Increasing prevalence of chronic diseases globally, which often require blood component therapies, directly contributes to the demand for more sophisticated apheresis equipment. The technological advancements that enhance machine efficiency and patient safety also play a significant role, as they meet the stringent standards of modern healthcare practices. Furthermore, there is a growing awareness and acceptance of apheresis as a preferred method for collecting high-quality blood components necessary for treating complex conditions. This acceptance is further buoyed by the healthcare shift towards personalized medicine, where treatments are tailored to the specific needs of patients, often requiring components collected via apheresis. Lastly, the expansion of healthcare infrastructure across emerging markets and the increasing investments in blood donation programs and specialty clinics are pivotal in driving the adoption of advanced apheresis equipment. These factors, coupled with the rising number of elderly populations at risk for chronic diseases, ensure sustained growth and innovation in the sector, meeting both current and future healthcare challenges.

SCOPE OF STUDY:

The report analyzes the Apheresis Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Disposable Apheresis Kits, Plasma & Component Separator, Other Types); Technology (Centrifugation, Membrane Filtration); Procedure (Plasmapheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, Other Procedures); Application (Neurology, Hematology, Renal Diseases, Other Applications)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 24 Featured) -

• B. Braun Melsungen AG
• Kaneka Corporation
• B. Braun Medical, Inc.
• Fresenius Kabi AG
• Miltenyi Biotec GmbH
• Fresenius SE & Co. KGaA
• Kawasumi Laboratories, Inc.
• Nikkiso Co., Ltd.
• Fresenius Medical Care AG & Co. KgaA
• Asahi Kasei Medical Co., Ltd.
• Haemonetics Corporation
• HemaCare Corporation
• Mallinckrodt Pharmaceuticals
• Fresenius Kabi USA
• Aferetica Srl

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.